本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Virax Biolabs Group Limited

0.2084
-0.0046-2.16%
成交量:13.43萬
成交額:2.79萬
市值:154.70萬
市盈率:-0.17
高:0.2210
開:0.2210
低:0.2013
收:0.2130
52周最高:1.95
52周最低:0.1999
股本:742.34萬
流通股本:698.55萬
量比:0.55
換手率:1.92%
股息:- -
股息率:- -
每股收益(TTM):-1.2376
每股收益(LYR):-1.6248
淨資產收益率:-83.82%
總資產收益率:-48.40%
市淨率:0.29
市盈率(LYR):-0.13

資料載入中...

2025/07/02

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/21

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/14

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/28

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/22

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/11/29

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/21

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/08/12

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/07/01

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/30

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/24

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers